stoxline Quote Chart Rank Option Currency Glossary
  
iShares Genomics Immunology and Healthcare ETF (IDNA)
25.075  0.345 (1.4%)    07-16 12:32
Open: 24.67
High: 25.0799
Volume: 16,279
  
Pre. Close: 24.73
Low: 24.67
Market Cap: 137(M)
Technical analysis
2024-07-16 12:21:15 PM
Short term     
Mid term     
Targets 6-month :  29.29 1-year :  34.21
Resists First :  25.07 Second :  29.29
Pivot price 23.61
Supports First :  23.6 Second :  22.69
MAs MA(5) :  24.48 MA(20) :  23.56
MA(100) :  23.64 MA(250) :  22.33
MACD MACD :  0.2 Signal :  0
%K %D K(14,3) :  94.5 D(3) :  90.8
RSI RSI(14): 69.6
52-week High :  25.21 Low :  17.32
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IDNA ] has closed It is unclear right now based on current values. 55% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 24.79 - 24.87 24.87 - 24.95
Low: 24.24 - 24.33 24.33 - 24.44
Close: 24.57 - 24.71 24.71 - 24.86
Company Description

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Headline News

Wed, 24 Jan 2024
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Finance

Thu, 04 Jan 2024
Has Biotechnology Bottomed Out? - Master Investor

Thu, 08 Jun 2023
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha

Mon, 17 Apr 2023
Megatrends: Gene Therapy and Editing - U.S News & World Report Money

Fri, 14 Apr 2023
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News

Wed, 15 Mar 2023
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android